Propacetamol hydrochloride

PreclinicalSmall molecule

Propacetamol hydrochloride is one of 3 small molecule programs targeting Local Infiltration. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Local InfiltrationCompleted

Local InfiltrationPreclinical

Completed

Competition

Competitive Landscape

4 competitors in Local Infiltration

#DrugCompanyPhaseTrials

Ultram

WWim Janssens

Preclinical

1 2

Liposomal Bupivacaine

TTLC Biopharmaceuticals, Inc.

Preclinical

1 3

Propacetamol hydrochloride

MMakassed General Hospital

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Local Infiltration1 trial

Dexamethasone Versus Local Infiltration Technique for Tonsillectomy in Children

Completed·MMakassed General Hospital·N/A·NCT02355678·129 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Propacetamol hydrochloride. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Propacetamol hydrochloride compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Propacetamol hydrochloride. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Makassed General Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: MMakassed General Hospital

Propacetamol hydrochloride

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Local Infiltration1 trial

References

Drug Info

Quick Facts

Related News